ERBB2 and neoplasm: Furthermore, the heterogeneous nature of HER2 staining in ESC prompts considerations about the optimal specimen/s type for testing, including biopsy versus hysterectomy, primary versus recurrent and metastatic lesions, and whole-tumor sections versus specific regions, as limited data currently exist.